Delivery Order SPE2DB20D3103-SPE2DB21FP7V4
Award Date 8/5/21
Potential Completion Date 8/6/21
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,164.62 for NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD) that provides logistics, acquisitions, and technical services to the U.S. military. The contract is not designated with a set-aside and was awarded on a full and open competition basis. Amerisourcebergen Drug Corp holds...
- This federal contract award is for the delivery of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $5,200.48, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of January 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,654.79 Firm Fixed Price Delivery Order is for the supply of NEUPOGEN 300 MCG/ML, a prescription medication, with a completion date of June 28, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds Indefinite Delivery Contracts (IDCs) with both the DLA, valued up to...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product NEUPOGEN 300 MCG/ML VIALML to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract is a Firm Fixed Price Delivery Order valued at $1,944.43, with a completion date of June 28, 2024. The contract is not set aside and was awarded on a full and open competition basis. AmerisourceBergen, a major pharmaceutical...
- This federal contract award is for the pharmaceutical product Neupogen 480 mcg/0.8 mL syringe, awarded to the prime contractor Amerisourcebergen Drug Corp. The $2,482.88 firm fixed price delivery order has an ultimate completion date of November 22, 2024. The contract was awarded on November 21, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency supplying medical products to military treatment facilities and veterans' healthcare programs. Amerisourcebergen, a...
- The Defense Logistics Agency awarded a $1,934.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Neupogen (filgrastim) 480 mcg/1.6 mL vials. The contract, awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a single delivery of this granulocyte-colony stimulating factor medication used to support patients undergoing chemotherapy and other medical treatments. This delivery order was competitively awarded with no set-aside...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order with a firm fixed price of $4,313.25 and a completion date of September 25, 2023. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD), and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor, through its parent company Cencora, Inc. The $4,487.97 fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract is not designated as a set-aside and is being fulfilled as part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA. This IDC serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,176.86 for pharmaceutical and medical supplies. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a major component of the Department of Defense (DoD) responsible for providing healthcare commodities to military treatment facilities, veterans' programs, and other federal medical institutions. The contract provides for the delivery of a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits to support military and government healthcare programs. The $16,964.13 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of pharmaceutical and medical products to the Department of Defense. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...